---
category: news
title: "Hepion Pharmaceuticals Presents Machine Learning “Learn and Confirm” Modeling Strategy at 4th ..."
excerpt: "Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA, “Hepion”), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”) - driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”) and liver disease,"
publishedDateTime: 2021-04-29T13:52:00Z
originalUrl: "https://apnews.com/press-release/globe-newswire/business-health-coronavirus-technology-87219646d2d65bc37f996c264e72bef7"
webUrl: "https://apnews.com/press-release/globe-newswire/business-health-coronavirus-technology-87219646d2d65bc37f996c264e72bef7"
type: article
quality: 26
heat: -1
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - Machine Learning
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

related:
  - title: "Lantern Pharma and Actuate Therapeutics Announce Research & Development Collaboration Leveraging Lantern's Artificial Intelligence Platform"
    excerpt: "Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ® artificial intelligence (\"A.I.\") platform to transform the cost, pace, and timeline of oncology drug discovery and development,"
    publishedDateTime: 2021-05-03T13:00:00Z
    webUrl: "https://markets.businessinsider.com/news/stocks/lantern-pharma-and-actuate-therapeutics-announce-research-development-collaboration-leveraging-lantern-s-artificial-intelligence-platform-1030377828"
    type: article
    provider:
      name: Business Insider
      domain: businessinsider.com
    quality: 35
    images:
      - url: "https://mma.prnewswire.com/media/1216507/Lantern_Pharma_Logo.jpg"
        width: 400
        height: 296
        isCached: true
  - title: "Hepion Pharmaceuticals Presents Machine Learning “Learn and Confirm” Modeling Strategy at 4th Global NASH Congress"
    excerpt: "Hepion Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on Artificial Intelligence- driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis and liver disease,"
    publishedDateTime: 2021-04-29T13:50:00Z
    webUrl: "https://www.nasdaq.com/press-release/hepion-pharmaceuticals-presents-machine-learning-learn-and-confirm-modeling-strategy"
    type: article
    provider:
      name: Nasdaq
      domain: nasdaq.com
    quality: 27

secured: "RTDQDQt111Wg5YtTuchcPKHFAOoqAM61YVoYZztLxQNlEMw3ccStBiCVPuHD+HbWWQSNT107RLC/lGUYC9u7QOUVXpQBjTTW8/DJZhsHCt/ktoiiUtUElODX7XPOoHyMfgTRf2CI1xsiwa+rWB+2rz+BLa1Q27ncIS+Ik3ec04kFSz4se5S9e8Uq31X8xobs5/q7udpUL54j4TRaicbFpozLqwcxFwRGRvGX8HFuah+NsZaDv85IUzlOhMb+D4G5FRglEtAzIiIu4EkuCn2n4xFk6U++T6o92/XK8SKlwfGuDdjm8wbTRdggQ26iSLRn1+JFI0NSagFEmm3z6R4N3+4SGdsYM6heEcDZzYxbAng=;PCXM9meRW2XtnijQBlOBZQ=="
---

